Angiogenic Squamous Dysplasia as a Biomarker to Predict Progression to Lung Cancer

被引:0
|
作者
Oak, Chulho [1 ]
Jang, Taewon [1 ]
Jung, Maanhong [1 ]
Chun, Bongkwon [2 ]
Park, Soonkew [3 ]
机构
[1] Kosin Univ, Coll Med, Dept Internal Med, Pusan 602030, South Korea
[2] Kosin Univ, Coll Med, Dept Pathol, Pusan 602030, South Korea
[3] Busan Natl Univ, Coll Med, Dept Internal Med, Pusan 602030, South Korea
关键词
Angiogenic squamous dysplasia; biomarker; lung cancer; ENDOTHELIAL GROWTH-FACTOR; TUMOR-ASSOCIATED MACROPHAGES; EXPRESSION; CELLS; CARCINOMA; BRONCHI;
D O I
暂无
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Angiogenic squamous dysplasia(ASD) is a term that has been introduced to describe a neoangiogenesis seen in bronchial dysplasias. One of many important angiogenic cytokines are the VEGFs. The VEGFs and their receptors are prime regulators of both physiological and pathological angiogenesis. But it is not clear whether ASD demonstrates the angiogenic switch or not, what is the mechanism of ASD. In this study, Immunohistochemical studies showed an expression of vascular endothelial growth factor in dysplastic bronchial epithelium. VEGF in the dysplastic cells in preneoplastic epithelium was observed in twenty-nine of 31 patients with ASD(93.5%), indicating that angiogenic switch occurred in early preneoplastic lesion including hyperplasia, metaplasia. ASD lesions were not identified in patients with COPD, whereas in 31 of 90 (34.4%) patients with squamous carcinoma, ASD was evident. In addition, the incidence of ASD increased as the hisotogical grade of preneoplastic lesion advanced, suggesting that the ASD may be a direct precursor lesion(P = 0.03). The author followed LIP the biologic behavior of dysplasia with respect to the status of ASD. There were significant associations between histological outcome and ASD status during the follow-up period(P = 0.04). These results suggested that ASD be used as biomarkers; to predict which dysplasias will progress to squamous cell carcinoma. Macrophages were identified in all(100%) tumor stroma and ASDs. The number of macrophage beneath ASD was significantly higher than that beneath other abnormal epithelium. In addition, the number of macrophages beneath ASD was significantly correlated with the Count of microvessels beneath ASD. The results of the present study Suggested that Angiogenic squamous dyplasia(ASD) may represent ail precursor of lung cancer and may serve as ail useful intermediate pathologic biomarker for early detection of lung cancer and chemoprevention. Macrophage beneath ASD may play ail important role in early angiogenesis of ASD.
引用
收藏
页码:855 / 861
页数:7
相关论文
共 50 条
  • [1] Angiogenic squamous dysplasia in bronchi of individuals at high risk for lung cancer
    Keith, RL
    Miller, YE
    Germmill, RM
    Drabkin, HA
    Dempsey, EC
    Kennedy, TC
    Prindiville, S
    Franklin, WA
    [J]. CLINICAL CANCER RESEARCH, 2000, 6 (05) : 1616 - 1625
  • [2] HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases
    Garufi, Alessia
    D'Orazi, Valerio
    Pistritto, Giuseppa
    Cirone, Mara
    D'Orazi, Gabriella
    [J]. CANCERS, 2023, 15 (05)
  • [3] Toll-Like Receptor 9 Is a Novel Biomarker for Esophageal Squamous Cell Dysplasia and Squamous Cell Carcinoma Progression
    Takala, Heikki
    Kauppila, Joonas H.
    Soini, Ylermi
    Selander, Katri S.
    Vuopala, Katri S.
    Lehenkari, Petri P.
    Saarnio, Juha
    Karttunen, Tuomo J.
    [J]. JOURNAL OF INNATE IMMUNITY, 2011, 3 (06) : 631 - 638
  • [4] Angiogenesis in bronchial dysplasia and angiogenic squamous dysplasia is associated with the development of immature vasculature
    Merrick, Daniel T.
    Buyers, Eliazbeth
    Miller, York E.
    Keith, Robert L.
    Kennedy, Timothy
    Franklin, Wilbur A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S442 - S442
  • [5] Inducible nitric oxide synthase as a predictor for progression to lung cancer in patients with bronchial squamous dysplasia, a per patient analysis
    Mohamed, Alaa
    Shibuya, Kiyoshi
    Yoshino, Ichiro
    Nakatani, Yukio
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [6] Fibrocytes As A Possible Cellular Biomarker For Anti-Angiogenic Therapy In Lung Cancer
    Goto, H.
    Mitsuhashi, A.
    Saijo, A.
    Ogino, H.
    Otsuka, K.
    Tobiume, M.
    Yoneda, H.
    Hanibuchi, M.
    Nishioka, Y.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [7] Tissue protein biomarker candidates to predict progression of esophageal squamous cell carcinoma and precancerous lesions
    Wang, Meng
    Smith, Jennifer S.
    Wei, Wen-Qiang
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2018, 1434 (01) : 59 - 69
  • [8] Xenotransplantability of human squamous cell lung cancer in nude mice is not affected by angiogenic factors
    Mattern, J
    Koomägi, R
    Volm, M
    [J]. ANTICANCER RESEARCH, 1999, 19 (3A) : 1941 - 1943
  • [9] Progression of esophageal dysplasia to cancer
    Appelman, Henry D.
    Matejcic, Marco
    Parker, M. Iqbal
    Riddell, Robert H.
    Salemme, Marianna
    Swanson, Paul E.
    Villanacci, Vincenzo
    [J]. 12TH OESO WORLD CONFERENCE: CANCERS OF THE ESOPHAGUS, 2014, 1325 : 96 - 107
  • [10] Prohibitin as a Potential Biomarker to Predict Osteoarthritis Progression
    Elseoudi, Abdellatif
    Elremaly, Wesam
    Elbakry, Mohamed
    Doucet, Roxanne
    Wang, DaShen
    Taheri, Maryam
    Pellicelli, Martin
    Picard, Cynthia
    Lavoie, Jean-Francois
    Lavigne, Patrick
    Lajeunesse, Daniel
    Moreau, Alain
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2023, 38 : 144 - 144